These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2058 related items for PubMed ID: 9652737

  • 1. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
    Li JJ, Rhim JS, Schlegel R, Vousden KH, Colburn NH.
    Oncogene; 1998 May 28; 16(21):2711-21. PubMed ID: 9652737
    [Abstract] [Full Text] [Related]

  • 2. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers.
    Suzukawa K, Colburn NH.
    Oncogene; 2002 Mar 28; 21(14):2181-90. PubMed ID: 11948401
    [Abstract] [Full Text] [Related]

  • 3. Inhibitors of both nuclear factor-kappaB and activator protein-1 activation block the neoplastic transformation response.
    Li JJ, Westergaard C, Ghosh P, Colburn NH.
    Cancer Res; 1997 Aug 15; 57(16):3569-76. PubMed ID: 9270030
    [Abstract] [Full Text] [Related]

  • 4. Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-alpha mediated repression of viral transcription and modification of the AP-1 transcription complex.
    Soto U, Das BC, Lengert M, Finzer P, zur Hausen H, Rösl F.
    Oncogene; 1999 May 27; 18(21):3187-98. PubMed ID: 10359524
    [Abstract] [Full Text] [Related]

  • 5. Differential inhibition of UVB-induced AP-1 and NF-kappaB transactivation by components of the jun bZIP domain.
    Cooper S, Ranger-Moore J, Bowden TG.
    Mol Carcinog; 2005 Jun 27; 43(2):108-16. PubMed ID: 15791649
    [Abstract] [Full Text] [Related]

  • 6. High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model.
    Zoumpourlis V, Papassava P, Linardopoulos S, Gillespie D, Balmain A, Pintzas A.
    Oncogene; 2000 Aug 17; 19(35):4011-21. PubMed ID: 10962557
    [Abstract] [Full Text] [Related]

  • 7. Activator protein 1 transcription factors are fundamental to v-rasHa-induced changes in gene expression in neoplastic keratinocytes.
    Rutberg SE, Adams TL, Glick A, Bonovich MT, Vinson C, Yuspa SH.
    Cancer Res; 2000 Nov 15; 60(22):6332-8. PubMed ID: 11103794
    [Abstract] [Full Text] [Related]

  • 8. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
    Zerbini LF, Wang Y, Cho JY, Libermann TA.
    Cancer Res; 2003 May 01; 63(9):2206-15. PubMed ID: 12727841
    [Abstract] [Full Text] [Related]

  • 9. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
    Echlin DR, Tae HJ, Mitin N, Taparowsky EJ.
    Oncogene; 2000 Mar 30; 19(14):1752-63. PubMed ID: 10777209
    [Abstract] [Full Text] [Related]

  • 10. Opposing activities of c-Fos and Fra-2 on AP-1 regulated transcriptional activity in mouse keratinocytes induced to differentiate by calcium and phorbol esters.
    Rutberg SE, Saez E, Lo S, Jang SI, Markova N, Spiegelman BM, Yuspa SH.
    Oncogene; 1997 Sep 30; 15(11):1337-46. PubMed ID: 9315102
    [Abstract] [Full Text] [Related]

  • 11. Expression of human p53 requires synergistic activation of transcription from the p53 promoter by AP-1, NF-kappaB and Myc/Max.
    Kirch HC, Flaswinkel S, Rumpf H, Brockmann D, Esche H.
    Oncogene; 1999 Apr 29; 18(17):2728-38. PubMed ID: 10348347
    [Abstract] [Full Text] [Related]

  • 12. Activation and inhibition of the AP-1 complex in human breast cancer cells.
    Chen TK, Smith LM, Gebhardt DK, Birrer MJ, Brown PH.
    Mol Carcinog; 1996 Mar 29; 15(3):215-26. PubMed ID: 8597534
    [Abstract] [Full Text] [Related]

  • 13. Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation.
    Yang HS, Knies JL, Stark C, Colburn NH.
    Oncogene; 2003 Jun 12; 22(24):3712-20. PubMed ID: 12802278
    [Abstract] [Full Text] [Related]

  • 14. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes.
    Nees M, Geoghegan JM, Hyman T, Frank S, Miller L, Woodworth CD.
    J Virol; 2001 May 12; 75(9):4283-96. PubMed ID: 11287578
    [Abstract] [Full Text] [Related]

  • 15. Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation.
    Watts RG, Huang C, Young MR, Li JJ, Dong Z, Pennie WD, Colburn NH.
    Oncogene; 1998 Dec 31; 17(26):3493-8. PubMed ID: 10030673
    [Abstract] [Full Text] [Related]

  • 16. Involvement of Rel, Fos, and Jun proteins in binding activity to the IL-2 promoter CD28 response element/AP-1 sequence in human T cells.
    McGuire KL, Iacobelli M.
    J Immunol; 1997 Aug 01; 159(3):1319-27. PubMed ID: 9233628
    [Abstract] [Full Text] [Related]

  • 17. Transcriptional activation of the human papillomavirus-16 P97 promoter by an 88-nucleotide enhancer containing distinct cell-dependent and AP-1-responsive modules.
    Cripe TP, Alderborn A, Anderson RD, Parkkinen S, Bergman P, Haugen TH, Pettersson U, Turek LP.
    New Biol; 1990 May 01; 2(5):450-63. PubMed ID: 1963084
    [Abstract] [Full Text] [Related]

  • 18. Structure and transcriptional regulation of BKJ, a novel AP-1 target gene activated during jun- or fos-induced fibroblast transformation.
    Hartl M, Bister K.
    Oncogene; 1998 Dec 03; 17(22):2901-13. PubMed ID: 9879996
    [Abstract] [Full Text] [Related]

  • 19. Opposing functions of ATF2 and Fos-like transcription factors in c-Jun-mediated myogenin expression and terminal differentiation of avian myoblasts.
    Daury L, Busson M, Tourkine N, Casas F, Cassar-Malek I, Wrutniak-Cabello C, Castellazzi M, Cabello G.
    Oncogene; 2001 Nov 29; 20(55):7998-8008. PubMed ID: 11753683
    [Abstract] [Full Text] [Related]

  • 20. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1.
    Okimoto T, Kohno K, Kuwano M, Gopas J, Kung HF, Ono M.
    Oncogene; 1996 Apr 18; 12(8):1625-33. PubMed ID: 8622882
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 103.